2025 annual financial data
Orchestra BioMed Holdings 2025 Operating margin
Orchestra BioMed Holdings 2025 operating margin with verified reported values.
Direct answer
Operating margin was -154.73%.
Operating income was -51,807,000 USD and net income was -52,701,000 USD.
Operating cash flow was Not available.
Get free Orchestra BioMed Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,482,000 USD
- Operating income
- -51,807,000 USD
- Net income
- -52,701,000 USD
- Operating cash flow
- Not available